| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $0.58 In Line |
| EPS GAAP Actual | $0.58 In Line |
| Revenue Actual | $1.74011B |
| Revenue Surprise | Beat by $1740.11M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.4356 |
| EPS GAAP Estimate | $3.4356 |
| Revenue Estimate | $2.0320929B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 12.9 | 5.48 | 12.57178 | 13.32694 | 1 |
| Dec 2026 | 11.25 | 6.28 | 11.15 | 11.35 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.64 | -1.57483 | 1.74011B | -3.31% | -230.09M |
| FQ1 2025 (Mar 2025) | 1.06 | 1.06 | 1.53649B | -7.09% | 1536.49M |
| FQ4 2024 (Dec 2024) | 1.79 | 1.79 | 1.56748B | -4.9% | 1567.48M |
| FQ3 2024 (Sep 2024) | 2.34 | 2.34 | 1.71372B | -7.04% | 1713.72M |
| FQ2 2024 (Jun 2024) | 2.85 | 2.85 | 1.79767B | -0.98% | 1797.67M |
| FQ1 2024 (Mar 2024) | 2.63 | 2.63 | 1.64542B | 6.14% | 1645.42M |
| FQ4 2023 (Dec 2023) | 2.46 | 2.46 | 1.64426B | 0.97% | 1644.26M |
| FQ3 2023 (Sep 2023) | 3.61 | 3.61 | 1.83444B | -17.46% | 1834.44M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.4356
Consensus Revenue Estimates
2.0320929B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.1188 | -- | 2.09829 | 2.13931 | 1 |
| FQ3 2027 (Sep 2027) | 2.97 | -- | 2.88621 | 3.0283 | 1 |
| FQ2 2027 (Jun 2027) | 2.83 | -- | 2.75016 | 2.88555 | 1 |
| FQ1 2027 (Mar 2027) | 1.71 | -- | 1.66175 | 1.74357 | 1 |
| FQ4 2026 (Oct 2026) | 3.4181 | -- | 3.31398 | 3.54275 | 0 |
| FQ3 2026 (Jul 2026) | 3.4773 | -- | 3.37138 | 3.60411 | 0 |
| FQ2 2026 (Jun 2026) | 3.4773 | 52.84 | 3.35444 | 3.65913 | 0 |
| FQ1 2026 (Mar 2026) | 2.0338 | 47.88 | 1.96194 | 2.14015 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.68B | -- | 1.66B | 1.69B | 1 |
| FQ3 2027 (Sep 2027) | 1.94B | -- | 1.89B | 1.96B | 2 |
| FQ2 2027 (Jun 2027) | 1.98B | -- | 1.94B | 2.01B | 2 |
| FQ1 2027 (Mar 2027) | 1.63B | -- | 1.6B | 1.66B | 2 |
| FQ4 2026 (Oct 2026) | 2.17B | -- | 2.12B | 2.23B | 1 |
| FQ3 2026 (Jul 2026) | 2.13B | -- | 2.08B | 2.19B | 1 |
| FQ2 2026 (Jun 2026) | 2.13B | 18.19 | 2.07B | 2.21B | 1 |
| FQ1 2026 (Mar 2026) | 1.75B | 12.42 | 1.71B | 1.83B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 3.21483 | 1.64 | -1.57483 | -96.03% |
| FQ1 2025 (Mar 2025) | 1.06 | 1.06 | 100% | |
| FQ4 2024 (Dec 2024) | 1.79 | 1.79 | 100% | |
| FQ3 2024 (Sep 2024) | 2.34 | 2.34 | 100% | |
| FQ2 2024 (Jun 2024) | 2.85 | 2.85 | 100% | |
| FQ1 2024 (Mar 2024) | 2.63 | 2.63 | 100% | |
| FQ4 2023 (Dec 2023) | 2.46 | 2.46 | 100% | |
| FQ3 2023 (Sep 2023) | 3.61 | 3.61 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.97B | $1.74B | $-230.09M | -13.22% |
| FQ1 2025 (Mar 2025) | $0B | $1.54B | $1536.49M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.57B | $1567.48M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.71B | $1713.72M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.8B | $1797.67M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.65B | $1645.42M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.64B | $1644.26M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.83B | $1834.44M | 100% |